Skip to main content
SpringerLink
Log in

Recreational Drug Abuse and Asthma

  • Chapter
Bronchial Asthma

  • 251 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. US Department of Health and Human Services, Public Health Services, Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse: 1991. Pub. No. 93–1980. 1993.

    Google Scholar 

  2. US Department of Health and Human Services, Public Health Services, Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse:1996. Series H-4, 1997.

    Google Scholar 

  3. Albertson TE, Gershwin ME, eds. Pulmonary complications of recreational drug usage. Clin Rev Allergy Immunol 1997; 16: 219–361.

    Google Scholar 

  4. Albertson TE, Walby WF, Derlet RW. Stimulant-induced pulmonary toxicity. Chest 1995; 108: 1140–1149.

    Article  PubMed  CAS  Google Scholar 

  5. Glassroth J, Adams GD, Schnoll S. The impact of substance abuse on the respiratory system. Chest 1987; 91: 596–602.

    Article  PubMed  CAS  Google Scholar 

  6. Phillips J, Wynne R. Cocaine: the Mystique and the Reality. New York, Avon, 1980.

    Google Scholar 

  7. Karch S. The history of cocaine toxicity. Hum Pathol 1989; 20: 1037–1039.

    Article  PubMed  CAS  Google Scholar 

  8. Gawin S, Ellinwood EH. Cocaine and other stimulants. Actions, abuse and treatment. N Engl J Med 1988; 318: 1173–1182.

    Article  PubMed  CAS  Google Scholar 

  9. US Department of Health and Human Services, Public Health Services, Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse. Population estimates 1988. Pub. No. 89–1636. 1989.

    Google Scholar 

  10. Siegel RK. New patterns of cocaine use: changing doses and routes. NIDA, Res Mono 1985; 62: 204–210.

    Google Scholar 

  11. Colliver J, Kapstein AN. Trends in cocaine abuse reflected in emergency room episodes reported to DAWN. Drug abuse warning network. Pub Health Rep 1991; 106: 59–68.

    CAS  Google Scholar 

  12. Murray RJ, Albin RJ, Mergner W, et al. Diffuse alveolar hemorrhage associated to cocaine smoking. Chest 1988; 893: 427–429.

    Article  Google Scholar 

  13. Cucco RA, Yoo AH, Cregler L, et al. Nonfatal pulmonary edema after “freebase” cocaine smoking. Am Rev Resp Dis 1987; 136: 179–181.

    Article  PubMed  CAS  Google Scholar 

  14. Kline JN, Hirasuna JD. Pulmonary edema after freebase cocaine smoking-not due to an adulterant. Chest 1990; 97: 1009–1010.

    Article  PubMed  CAS  Google Scholar 

  15. Patel RC, Dutta D, Schofield SA. Freebase cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann Int Med 1987; 107: 186–187.

    PubMed  CAS  Google Scholar 

  16. Ettinger NA. A review of the respiratory effects of smoking cocaine. Am J Med 1989; 87: 664–668.

    Article  PubMed  CAS  Google Scholar 

  17. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 1990; 88: 325–331.

    Article  PubMed  CAS  Google Scholar 

  18. Rich JA, Singer DE. Cocaine-related symptoms in patients presenting to an urban emergency department. Ann Emerg Med 1991; 20: 616–621.

    Article  PubMed  CAS  Google Scholar 

  19. Siegel R. Cocaine smoking. J Psychoactive Drugs 1982; 14: 321–325.

    Article  Google Scholar 

  20. Jeri F, Sanchez C, del Pozo T, et al. Further experience with the syndrome produced by coca paste smoking. Bull Narcotics 1978; 30; 1–11.

    CAS  Google Scholar 

  21. Waldbott GL. Asthma due to a local anesthetic. JAMA 1932; 99: 1942–1945.

    Article  Google Scholar 

  22. Weiss KB, Gergen PG, Crain EF. Inner city asthma. The epidemiology of an emerging US public health concern. Chest 1992; 101: 362s - 367s.

    PubMed  CAS  Google Scholar 

  23. Greenberger PA, Miller TP, Lifschultz B. Circumstances surrounding deaths from asthma in Cook County, Illinois. Allg Proc 1993; 14: 321–326.

    Article  CAS  Google Scholar 

  24. Levenson T, Greenberger PA, Donoghue ER, et al. Asthma deaths confounded by substance abuse. An assessment of asthma. Chest 1996; 110: 664–710.

    Article  Google Scholar 

  25. Osborn HH, Tang M, Bradley K, et al. New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med 1997; 4: 689–692.

    Article  PubMed  CAS  Google Scholar 

  26. Panacek EA, Jouriles NJ, Singer A, et al. Is unexplained bronchospasm associated with the use of cocaine? Ann Emerg Med 1991; 20: 211–212.

    Google Scholar 

  27. Rubin RB, Neugarten J. Cocaine-associated asthma. Am J Med 1990; 88: 438–439.

    Article  PubMed  CAS  Google Scholar 

  28. Rebhun J. Association of asthma and freebase smoking. Ann Allergy 1988; 60: 339–342.

    PubMed  CAS  Google Scholar 

  29. Rao AN, Polos PG, Walther FA. Crack abuse and asthma: a fatal combination. NYS J Med 1990; 90: 511–512.

    CAS  Google Scholar 

  30. Averbach M, Casey KK, Frank E. Near-fatal status asthmaticus induced by nasal insufflation of cocaine. So Med J 1996; 89: 340–341.

    Article  CAS  Google Scholar 

  31. Meisels IS, Loke J. The pulmonary effects of free-base cocaine: a review. Clev Clin J Med 1993; 60: 325–329.

    CAS  Google Scholar 

  32. Kissner DG, Lawrence WD, Selis JE, et al. Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis 1987; 136: 1250–1252.

    Article  PubMed  CAS  Google Scholar 

  33. Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. NEngl JMed 1994; 330: 1329–1334.

    Article  CAS  Google Scholar 

  34. Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med 1988; 17: 1243–1247.

    Article  PubMed  CAS  Google Scholar 

  35. Dean NC, Clark HW, Doherty JJ, et al. Pulmonary function in heavy users of `freebase’ cocaine. Am Rev Respir Dis 1988; 137s: 489.

    Google Scholar 

  36. Weiss RD, Goldenheim PD, Mirin SM, et al. Pulmonary dysfunction in cocaine smokers. Am J Psychiatry 1981; 138: 1110–1112.

    PubMed  CAS  Google Scholar 

  37. Weiss RD, Tilles DS, Goldenheim PD, et al. Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. Drug Alcohol Dependence 1987; 19: 271–276.

    Article  CAS  Google Scholar 

  38. Susskind H, Weber DA, Volkow ND, et al. Increased lung permeability following long-term use of free-base cocaine. Chest 1991; 100: 903–909.

    Article  PubMed  CAS  Google Scholar 

  39. Itkonen J, Schnoll S, Glassroth J, et al. Pulmonary dysfunction in `freebase’ cocaine users. Arch Internal Med 1984; 144: 2195–2197.

    Article  CAS  Google Scholar 

  40. Tashkin DP, Kleerup EC, Koyal SN, et al. Acute effects of inhaled and IV cocaine on airway dynamics. Chest 1996; 110: 904–910.

    Article  PubMed  CAS  Google Scholar 

  41. Tashkin DP, Khalsa ME, Gorelick D, et al. Pulmonary status of habitual cocaine smokers. Am Rev Respir Dis 1992; 145: 92–100.

    Article  PubMed  CAS  Google Scholar 

  42. Derlet R, Heischober B. Methamphetamine stimulant of the 1990’s? West J Med 1990; 153: 625–628.

    PubMed  CAS  Google Scholar 

  43. Bailey D, Shaw R. Cocaine and methamphetamine related deaths in San Diego County (1987): homicides and accidental overdoses. J Forensic Sci 1989; 34: 407–422.

    PubMed  CAS  Google Scholar 

  44. Anderson R, Reed W, Hillis L. History, epidemiology, and medical complications of nasal inhaler abuse. J Toxicol Clin Toxicol 1982; 19: 95–107.

    Article  PubMed  CAS  Google Scholar 

  45. Mark EJ, Patalas ED, Kchang HT, et al. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phenteramine. N Engl J Med 1997; 337: 602–606.

    Article  PubMed  CAS  Google Scholar 

  46. Dillon KA, Putnam KG, Avorn JL. Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phenteramine. JAMA 1997; 278: 1320.

    Article  PubMed  CAS  Google Scholar 

  47. Delcroix M, Kurz X, Walckiers D, et al. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium. Eur Respir J 1998; 12: 271–276.

    Article  PubMed  CAS  Google Scholar 

  48. Voelkel NF, Clarke WR, Higgenbottam T, et al. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned? Am J Respir Crit Care Med 1997; 155: 786–788.

    PubMed  CAS  Google Scholar 

  49. Schaiberger PH, Kennedy TC, Miller FC, et al. Pulmonary hypertension associated with long-term inhalation of “crank” methamphetamine. Chest 1993; 104: 614–616.

    Article  PubMed  CAS  Google Scholar 

  50. Nestor T, Tamamoto W, Kam T, et al. Acute pulmonary edema caused by crystalline methamphetamine. Lancet 1989; 2: 1277–1278.

    Article  PubMed  CAS  Google Scholar 

  51. Nestor T, Tamamoto W, Kam T, et al. Crystal methamphetamine-induced acute pulmonary edema: a case report. Haw Med J 1989; 48: 457–459.

    CAS  Google Scholar 

  52. Seaman ME. Pneumomediastinum related to methamphetamine use. Ann Emerg Med 1990; 8: 141–149.

    CAS  Google Scholar 

  53. Suhl J, Gorelick D. Pulmonary function in male freebase cocaine smokers. Am Rev Respir Dis 1988; 137s: 488.

    Google Scholar 

  54. Dowling GP, McDonough ET, Bost RO. ‘Eve’ and ‘Ecstasy’. A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987; 257: 1615–1617.

    Article  PubMed  CAS  Google Scholar 

  55. Schmidt RA, Glenny RW, Godwin JD, et al. Panlobular emphysema in young intravenous ritalin abusers. Am Rev Respir Dis 1991; 143: 649–656.

    PubMed  CAS  Google Scholar 

  56. Sherman CB, Hudson LD, Pierson DJ. Sever precocious emphysema in intravenous methlyphenidate (ritalin) abusers. Chest 1987; 92: 1085–1087.

    Article  PubMed  CAS  Google Scholar 

  57. Pare JP, Cote G, Fraser RS. Long-term follow-up of drug abusers with intravenous talcosis. Am Rev Respir Dis 1989; 139: 233–241.

    Article  PubMed  CAS  Google Scholar 

  58. Reiseine T, Pasternak K. The pharmacologic basics of therapeutics, in (Hardman JF, Gillman AG, Limbird LE, eds.), New York, McGraw-Hill, pp. 521–555.

    Google Scholar 

  59. Brownstein MJ. Brief history of opiates, opiod peptides, and opiod receptors. Proc Natl Acad Sci USA 1993; 90: 5391–5393.

    Article  PubMed  CAS  Google Scholar 

  60. Lao PN. Effects of opiates on the lungs. Clin Rev Allergy Immunol 1997; 15: 291–305.

    Article  PubMed  CAS  Google Scholar 

  61. Goldstein DS, Karpel JP, Appel D, et al. Bullous pulmonary damage in users of intravenous drugs. Chest 1986; 89: 266–269.

    Article  PubMed  CAS  Google Scholar 

  62. Kringsholm B, Christoffersen P. The nature and the occurrence of birefringent material in different organs in fatal drug addiction. For Sci Int 1987; 34: 53–62.

    CAS  Google Scholar 

  63. Del los Santos-Sartre S, Capote-Gil F, Gonzales-Castro A. Airway obstruction and heroin inhalation. Lancet 1986; 2: 1158.

    Article  Google Scholar 

  64. Oliver RM. Bronchospasm and heroin inhalation. Lancet 1986; 1: 915.

    Article  PubMed  CAS  Google Scholar 

  65. Anderson K. Bronchospasm and intravenous street heroin. Lancet 1986; 1: 1208.

    Article  PubMed  CAS  Google Scholar 

  66. Hughes S, Calverley PMA. Heroin inhalation and asthma. Br Med J 1988; 297: 1611–1612.

    Google Scholar 

  67. Sapira JD. The narcotic addict as a medical patient. Am J Med 1968; 45: 555–587.

    Article  PubMed  CAS  Google Scholar 

  68. Ghodse AH, Myles JS. Asthma in opiate addicts. J Psychosom Res 1987; 31: 41–44.

    Article  PubMed  CAS  Google Scholar 

  69. Spiritus EM, Wilson AF, Berke RA. Lung scans in asymptomatic heroin addicts. Am Rev Respir Dis 1973; 108: 994–996.

    PubMed  CAS  Google Scholar 

  70. Camargo G, Colp C. Pulmonary function studies in ex-heroin users. Chest 1975; 67: 331–334.

    Article  PubMed  CAS  Google Scholar 

  71. Overland ES, Nolan AJ, Hopewell PC. Alteration of pulmonary function in intravenous abnormalities. Am J Med 1980; 68: 231–237.

    Article  PubMed  CAS  Google Scholar 

  72. Eschenbacher WL, Bethel RA, Boushey HA, et al. Morphine sulfate inhibits bronchoconstriction in subjects with mild asthma whose responses are inhibited by atropine. Am Rev Respir Dis 1984; 130: 363–367.

    PubMed  CAS  Google Scholar 

  73. Mestiri M, Lurie A, Frossard N, et al. Effect of inhaled morphine on the bronchial responsiveness to isocapnic hyperventilation in patients with allergic asthma. Eur J Clin Pharm 1991; 41: 621.

    Article  CAS  Google Scholar 

  74. Field PI, Simmul R, Bell SC, et al. Evidence for opiod modulation and generation of prostaglandins in sulphur dioxide-induced bronchoconstriction. Thorax 1996; 51: 159–163.

    Article  PubMed  CAS  Google Scholar 

  75. Dixon WE, Brodie TG. Contributions to the physiology of the lung. The bronchial muscles, their innervation and the action of drugs upon them. J Physiol 1903; 19: 979–1173.

    Google Scholar 

  76. Shermano I, Wendel H. Effect of morphine hydrochloride and morphine sulfate on the lung capacity of intact dogs. J Pharmacol Exp Ther 1978; 149: 379–384.

    Google Scholar 

  77. Schurig JE, Cavanagh RL, Buyinski A. Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure, and venous plasma histamine in the anesthetized dog. Arch Int Pharmacodyn 1978; 233: 1966–2304.

    Google Scholar 

  78. Adrian J Rovenstine EA. The effect of anesthetic drugs upon bronchi and bronchioles of excised lung tissue. Anesth 1943; 4: 253–262.

    Article  Google Scholar 

  79. Leslie RDG, Bellamy D, Pyke DA. Asthma induced by enkephalin. Br Med J 1980; 280: 16–18.

    Google Scholar 

  80. Rogers DF, Barnes PJ. Opiod inhibition of neurally mediated mucus secretion in human bronchi. Lancet 1989; 1: 930–931.

    Article  PubMed  CAS  Google Scholar 

  81. Russel JA, Simons EJ. Modulation of cholinergic neurotransmission in airways by enkephalin. JAppl Physiol 1985; 58: 853–858.

    Google Scholar 

  82. Popa V. Codeine-induced bronchoconstriction and putative bronchial opiate receptors in asthmatic subjects. Pulm Pharm 1994; 7: 333–341.

    Article  CAS  Google Scholar 

  83. Willette RN, Barcas PP, Krieger AJ et al. Pulmonary resistance and compliance changes evoked by pulmonary opiate receptor stimulation. Eur J Pharm 1983; 91: 181–188.

    Article  CAS  Google Scholar 

  84. Shaikh WA. Allergy to heroin. Allergy 1990; 45: 555–556.

    Article  PubMed  CAS  Google Scholar 

  85. Biagnini RE, Klincewicz SL, Henningsen GM. Antibodies to morphine in workers exposed to opiates at a narcotics manufacturing facility and evidence for similar antibodies in heroin abusers. Life Sci 1993; 53: 99–105.

    Article  Google Scholar 

  86. Ulinski S, Palczynski C, Gorski P. Occupational rhinitis and bronchial asthma due to morphine: evidence from inhalational and nasal challenges. Allergy 1996; 51: 914–918.

    PubMed  CAS  Google Scholar 

  87. Maykut MO. Health consequences of acute and chronic marihuana use. Prog Neuropsychopharm Biol Psych 1985; 9: 209–238.

    Article  CAS  Google Scholar 

  88. Van Hoozen BE, Cross CE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol 1997; 15: 243–269.

    Article  PubMed  Google Scholar 

  89. Nahas G, Latour C. The human toxicity of marijuana. Med JAust 1992; 156: 495–497.

    CAS  Google Scholar 

  90. Crawley JN, Corwin RL, Robinson JK, et al. Andanamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 1993; 46: 967–972.

    Article  PubMed  CAS  Google Scholar 

  91. Miller WE, Spiekerman RE, Hepper NG. Pneumomediastinum resulting from performing Valsalva maneuvers during marijuana smoking. Chest 1972; 62: 233–234.

    Article  PubMed  CAS  Google Scholar 

  92. Mattox KL. Pneumomediastinum in heroin and marijuana users. JACEP 1976; 5: 26–28.

    Article  PubMed  CAS  Google Scholar 

  93. Polen MR, Sidney S, Tekawa IS, et al. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 1993; 158: 596–601.

    PubMed  CAS  Google Scholar 

  94. Gong H, Fligiel S, Tashkin DP, et al. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis 1987; 136: 142–149.

    Article  PubMed  Google Scholar 

  95. Taylor FM. Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J 1988; 81: 1213–1216.

    Article  PubMed  Google Scholar 

  96. Ferguson RP, Hasson J, Walker S. Metastatic lung cancer in a young marijuana smoker. JAMA 1989; 261: 41–42.

    Article  PubMed  CAS  Google Scholar 

  97. Donald PJ. Marijuana smoking-possible cause of head and neck carcinoma in young patients. Otolaryng Head Neck Surg 1986; 94: 517–522.

    CAS  Google Scholar 

  98. Caplan GA, Brigham BA. Marijuana smoking and carcinoma of the tongue. Is there an association? Cancer 1990; 66: 1005–1006.

    Article  PubMed  CAS  Google Scholar 

  99. Wu TZ, Tashkin DP, Djahed B, et al. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988; 318: 347–351.

    Article  PubMed  CAS  Google Scholar 

  100. Tashkin DP, Gliederer F, Rose J, et al. Tar, CO and A9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharm Biochem Behav 1991; 40: 657–661.

    Article  CAS  Google Scholar 

  101. Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of tobacco and marijuana, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis 1987; 135: 209–216.

    PubMed  CAS  Google Scholar 

  102. Bloom JW, Kaltenborn WT, Paoletti P, et al. Respiratory effects on non-tobacco cigarettes. Br Med J 1987; 295: 1516–1518.

    Article  CAS  Google Scholar 

  103. Williams SJ, Hartley JPR, Graham JDP. Bronchodilator effect of 41-tetrahydrocannabinol administered by aerosol to asthmatic patients. Thorax 1976; 31: 720–723.

    Article  PubMed  CAS  Google Scholar 

  104. Tashkin DP, Shapiro FJ, Frank IM. Acute effects of smoked marijuana and 49tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis 1974; 109: 420–428.

    PubMed  CAS  Google Scholar 

  105. Vachon L, Fitzgerald MX, Solliday NH, et al. Single-dose effect of marijuana smoke: bronchial dynamics and respiratory center sensitivity in normal subjects. N Engl J Med 1973; 288: 985–987.

    Article  PubMed  CAS  Google Scholar 

  106. Tashkin DP, Shapiro BJ, Lee E, et al. Subacute effects of heavy marijuana smoking on pulmonary function in healthy men. N Engl J Med 1976; 294: 125–129.

    Article  PubMed  CAS  Google Scholar 

  107. Tashkin DP, Simmons MS, Chang P, et al. Effects of smoked substance abuse on nonspecific airway hyperresponsiveness. Am Rev Respir Dis 1993; 147: 97–103.

    Article  PubMed  CAS  Google Scholar 

  108. Friedman H, Klein TW, Newton C, et al. Marijuana, receptors and immunomodulation. Adv Exp Med Biol 1995; 373: 103–113.

    Article  PubMed  CAS  Google Scholar 

  109. Specter SC, Klein TW, Newton C, et al. Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannibinol. Int J Immunopharmacol 1986; 8: 741–745.

    Article  PubMed  CAS  Google Scholar 

  110. US Center of Disease Control and Prevention. Tobacco use and usual source of cigarettes among high school students-United States, 1995. MMWR 1996; 45: 413–418.

    Google Scholar 

  111. US Center for Disease Control and Prevention. Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users-United States,1993. MMWR 1993; 43: 745–750.

    Google Scholar 

  112. American thoracic society. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861–865.

    Google Scholar 

  113. US Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Preventing tobacco use among young people: a report of the Surgeon General. 1994.

    Google Scholar 

  114. Giovino GA, Henningfield JE, Tomar SL et al. Epidemiology of tobacco use and dependence. Epidemiol Rev 1995; 17: 48–65.

    PubMed  CAS  Google Scholar 

  115. Lucchesi BR, Schuster CR, Emley GS. The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with tobacco alkazoid. Clin Pharmacol Ther 1967; 8: 789–796.

    PubMed  CAS  Google Scholar 

  116. Swedburg MD. Nicotine dependency: animal studies. Nicotine Psychopharmacology: Molecular, Cellular, and Behavioral Patterns. (Wonnacott S, ed.), Oxford, Oxford University Press, 1990, pp. 38–76.

    Google Scholar 

  117. Hanrahan JP, Tager IB, Segal MR, et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992; 145: 1129–1135.

    Article  PubMed  CAS  Google Scholar 

  118. Burchfiel CM, Wiggins MW, Keller JB, et al. Passive smoking in childhood: Respiratory conditions and pulmonary function in Tecumseh, Michigan. Am Rev Respir Dis 1986; 133: 966–973.

    PubMed  CAS  Google Scholar 

  119. Clark SJ, Warner JO, Dean TP. Passive smoking amongst asthmatic children. Questionnaire or objective assessment? Clin Exp Allergy 1994; 24: 276–280.

    Article  PubMed  CAS  Google Scholar 

  120. Willers S, Svenonius E, Skarping G. Passive smoking and childhood asthma. Allergy 1991; 46: 330–334.

    Article  PubMed  CAS  Google Scholar 

  121. Cunningham J, Dockery DW, Speizer FE. Maternal smoking during pregnancy as a predictor of lung function in children. Am J Epidemiol 1994; 139: 1139–1152.

    PubMed  CAS  Google Scholar 

  122. Weiss ST. Environmental risk factors in childhood asthma. Clin Exp Allergy 1998; 28: 29–34.

    Article  PubMed  Google Scholar 

  123. Ehrlich RI, Du Toit D, Jordaan E, et al. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking. Am J Respir Crit Care Med 1996; 154: 681–688.

    PubMed  CAS  Google Scholar 

  124. Eisner MD, Yelin EH, Henke J, et al. Environmental tobacco smoke and adult asthma. The impact of changing exposure status on health outcomes. Am J Respir Crit Care Med 1998; 158: 170–175.

    PubMed  CAS  Google Scholar 

  125. Flodin U, Jonsson P, Ziegler J, et al. An epidemiologic study of bronchial asthma and smoking. Epidemiology 1995; 6: 503–505.

    Article  PubMed  CAS  Google Scholar 

  126. White JR, Froeb HF. Small-airways dysfunction in nonsmokers chronically exposed to tobacco smoke. N Engl J Med 1980; 302: 720–723.

    Article  PubMed  CAS  Google Scholar 

  127. Knight JM, Eliopoulos C, Klein J, et al. Pharmacokinetic predisposition to nicotine from environmental tobacco smoke: a risk factor for pediatric asthma. J Asthma 1998; 35: 113–117.

    Article  PubMed  CAS  Google Scholar 

  128. Wakefield M, Ruffin R, Campbell D, et al. Smoking-related beliefs and behaviour among adults with asthma in a representative population sample. Aust NZ J Med 1995; 25: 12–17.

    Article  CAS  Google Scholar 

  129. Irvine L, Crombie IK, Clark RA, et al. Advising parents of asthmatic children on passive smoking: randomized controlled trial. Br Med J 1999; 318: 1456–1459.

    Article  CAS  Google Scholar 

  130. Chadwick O, Anderson R, Bland M, et al. Neuropsychological consequences of volatile substance abuse: a population based study of secondary school pupils. Br Med J 1989; 298: 1679–1683.

    Article  CAS  Google Scholar 

  131. Schickler KN, Lane EE, Seitz K, et al. Solvent abuse associated pulmonary abnormalities. Concepts Alcohol Subst Abuse 1984; 3: 75–81.

    Article  Google Scholar 

  132. Meredith TJ, Ruprah M, Liddle A, et al. Diagnosis and treatment of acute poisoning with volatile substances. Hum Toxicol 1989; 8: 277–286.

    Article  PubMed  CAS  Google Scholar 

  133. Cartwright TR, Brown D, Brashear RE. Pulmonary infiltrates following butane `fire-breathing.’ Arch Int Med 1983; 143: 2007–2008.

    Article  CAS  Google Scholar 

  134. Ungerleider JT, Fisher DD, Fuller M. The dangers of LSD. JAMA 1966; 197: 389.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Nicholas J. Kenyon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy E. Albertson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, University of California at Davis, Davis, CA, USA

    M. Eric Gershwin MD  & Timothy E. Albertson MD, PHD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kenyon, N.J., Albertson, T.E. (2001). Recreational Drug Abuse and Asthma. In: Gershwin, M.E., Albertson, T.E. (eds) Bronchial Asthma. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-127-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-127-5_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4687-7

  • Online ISBN: 978-1-59259-127-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation